Loading companies…
D
DataHow
Switzerland · Enterprise software · Biotech
DataHow builds DataHowLab, a process-modeling and digital-twin platform for biopharmaceutical process engineers and manufacturers.
Product and customers
It combines process knowledge, experimental and production data, data science, and AI models to simulate process behavior, share validated recipes, and guide targeted experiments instead of relying only on trial and error. The software is in use by bioprocess teams, with the company extending it toward real-time monitoring and model-driven process control.
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Bridge financing | Undisclosed | Momenta Ventures — LeadHINA Bioventures — ParticipantRockwell Automation — ParticipantZürcher Kantonalbank — Participant |
Investors
Momenta VenturesLed Bridge financingHINA BioventuresJoined Bridge financingRockwell AutomationJoined Bridge financingZürcher KantonalbankJoined Bridge financingCoverage
Sep 2, 2026DataHow · Bridge financingSimilar companies
AAligatorAI media intelligence for PR and marketing teams to monitor brand coverage, understand audience and competitor sentiment, and spot reputational risks across channels and languages.$1.2M · Seed
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
AventixAventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.€1.2M · Pre-seed